Argonautica Private Wealth Management, Inc Gilead Sciences, Inc. Transaction History
Argonautica Private Wealth Management, Inc
- $343 Billion
- Q3 2025
A detailed history of Argonautica Private Wealth Management, Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Argonautica Private Wealth Management, Inc holds 3,425 shares of GILD stock, worth $425,008. This represents 0.11% of its overall portfolio holdings.
Number of Shares
3,425
Previous 3,425
-0.0%
Holding current value
$425,008
Previous $380 Million
0.12%
% of portfolio
0.11%
Previous 0.12%
Shares
11 transactions
Others Institutions Holding GILD
# of Institutions
2,414Shares Held
1.01BCall Options Held
8.51MPut Options Held
7.32M-
Vanguard Group Inc Valley Forge, PA121MShares$15 Billion0.23% of portfolio
-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...